Other

Licensing Arrangements

Moderna Licensing Arrangements increased by 3019.4% to $967.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19240.0%, from $5.00M to $967.00M. Over 3 years (FY 2022 to FY 2025), Licensing Arrangements shows a downward trend with a -46.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ1 2026May 1, 2026
Metric ID: other_accrued_royalties_current

Historical Data

13 periods
 Q4 '22Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$203.00M$12.00M$78.00M$122.00M$8.00M$10.00M$92.00M$46.00M$5.00M$6.00M$42.00M$31.00M$967.00M
QoQ Change-94.1%+550.0%+56.4%-93.4%+25.0%+820.0%-50.0%-89.1%+20.0%+600.0%-26.2%>999%
YoY Change-39.9%-16.7%+17.9%-62.3%-37.5%-40.0%-54.3%-32.6%>999%
Range$5.00M$967.00M
CAGR+68.3%
Avg YoY Growth>999%
Median YoY Growth-37.5%

Licensing Arrangements at Other Companies

Frequently Asked Questions

What is Moderna's licensing arrangements?
Moderna (MRNA) reported licensing arrangements of $967.00M in Q1 2026.
How has Moderna's licensing arrangements changed year-over-year?
Moderna's licensing arrangements increased by 19240.0% year-over-year, from $5.00M to $967.00M.
What is the long-term trend for Moderna's licensing arrangements?
Over 3 years (2022 to 2025), Moderna's licensing arrangements has grown at a -46.5% compound annual growth rate (CAGR), from $203.00M to $31.00M.